Literature DB >> 4238528

High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity.

V J Marder, N R Shulman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4238528

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  23 in total

1.  Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system.

Authors:  J F Liang; Y T Li; M E Connell; V C Yang
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspective.

Authors:  U Martin; B Kaufmann; G Neugebauer
Journal:  Clin Pharmacokinet       Date:  1999-04       Impact factor: 6.447

3.  Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.

Authors:  C A Goodwin; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

4.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 5.  New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.

Authors:  W Nieuwenhuizen
Journal:  Blut       Date:  1988-11

6.  Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.

Authors:  J T Wilde; W E Thomas; D A Lane; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

7.  Coagulation changes of septic shock in the sub-human primate and their relationship to hemodynamic changes.

Authors:  D L Horowitz; R B Moquin; C M Herman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

8.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

Authors:  E Plow; T S Edgington
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.

Authors:  D J Fitzgerald; M Hanson; G A FitzGerald
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

10.  Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.

Authors:  S Niewiarowski; A F Senyi; P Gillies
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.